U.S. flag

An official website of the United States government

NM_000525.4(KCNJ11):c.406C>A (p.Arg136Ser) AND Type 2 diabetes mellitus

Germline classification:
Likely risk allele (1 submission)
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002227237.3

Allele description [Variation Report for NM_000525.4(KCNJ11):c.406C>A (p.Arg136Ser)]

NM_000525.4(KCNJ11):c.406C>A (p.Arg136Ser)

Gene:
KCNJ11:potassium inwardly rectifying channel subfamily J member 11 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11p15.1
Genomic location:
Preferred name:
NM_000525.4(KCNJ11):c.406C>A (p.Arg136Ser)
HGVS:
  • NC_000011.10:g.17387686G>T
  • NG_012446.1:g.5974C>A
  • NM_000525.4:c.406C>AMANE SELECT
  • NM_001166290.2:c.145C>A
  • NM_001377296.1:c.145C>A
  • NM_001377297.1:c.145C>A
  • NP_000516.3:p.Arg136Ser
  • NP_000516.3:p.Arg136Ser
  • NP_001159762.1:p.Arg49Ser
  • NP_001364225.1:p.Arg49Ser
  • NP_001364226.1:p.Arg49Ser
  • NC_000011.9:g.17409233G>T
  • NM_000525.3:c.406C>A
Protein change:
R136S
Links:
dbSNP: rs766891274
NCBI 1000 Genomes Browser:
rs766891274
Molecular consequence:
  • NM_000525.4:c.406C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001166290.2:c.145C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001377296.1:c.145C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001377297.1:c.145C>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Type 2 diabetes mellitus
Synonyms:
DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; Type II diabetes mellitus; Diabetes mellitus, noninsulin-dependent, late onset
Identifiers:
MONDO: MONDO:0005148; MeSH: D003924; MedGen: C0011860; OMIM: 125853; Human Phenotype Ontology: HP:0005978

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002506501Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic
criteria provided, single submitter

(K & H Uppaluri Personalized Medicine Clinic Variant Classification & Assertion Criteria_Updated V.1)
Likely risk allelesomaticresearch

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedsomaticyesnot providednot providednot providednot providednot providedresearch

Citations

PubMed

A novel mutation KCNJ11 R136C caused KCNJ11-MODY.

Chen Y, Hu X, Cui J, Zhao M, Yao H.

Diabetol Metab Syndr. 2021 Aug 31;13(1):91. doi: 10.1186/s13098-021-00708-6.

PubMed [citation]
PMID:
34465386
PMCID:
PMC8406974

Details of each submission

From Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic, SCV002506501.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providedresearch PubMed (1)

Description

rs766891274 variant of in KCNJ11 gene can cause decreased production and secretion of insulin. This can lead to MODY which is responsive to oral sulfonylureas.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1somaticyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 16, 2024